Synopsis
“Rise in corporate loan growth is a strong indicator of economic activity. Capex growth is the start of a long runway of an entire set of economic activity in the entire valuation that happened. So this is a very strong indicator and a very good thing for the economy going ahead.”

We are a $3-trillion economy and even by IMF estimates, roughly in eight years we will be say double the size. Adding $3 trillion worth of economic potential for a lot of goods and services businesses is a historical thing from an economic perspective. A lot of business will get generated and that is more important than India going to double income in the next eight years,” says Mrinal Singh, CEO & CIO, InCred AMC.

Corporate loans have crossed the Rs 29 lakh crore mark once again and that is important because in the third quarter, a lot of corporate and PSU banks have made a comeback and they are reporting good data as well as commentary. Corporate enquiries have come back and hence the loan, credit growth is looking upwards yet again. What are your thoughts on credit growth and the role of the banking sector now?

It is a very pertinent data and very strong indicator of economic activity, particularly in the manufacturing side, getting picked up. The credit growth data is the lead indicator that most analysts look for. The conversations surrounding – be it the lenders, be it the borrowers in that space – are very encouraging. We are clearly seeing that the economy or a section of corporate India in particular has walked into the capex mode. Generally, we have seen that this is the start of a long runway oof an entire set of economic activity in the entire valuation that happened. So this is a very strong indicator and a very good thing for the economy going ahead.

I was going through your presentation and one of the points which caught my attention was the per capita income crossing the $2,000 mark now and the estimate is that it may cross the $3,000 mark by 2025, give or take six months. What does this really mean for categories which are likely to see a good boost?

In my view, it is the holy grail of growth. IMF says our per capita income is something around $2200 and by FY25 they estimate that we would cross $3,000 and by 2030, we would cross $4,700 per capita. Now the important point is the $2,000 to $3,000 transition. We have had this kind of transition in some phases in the last 50 years with a lot of economies. Interestingly, there is a very standard set of things that households spend on when they go about seeing that income transition and that includes things like individual mobility, education, leisure, travel, entertainment, consumer durables and things like that.

It may be no different in our economy. This will by far be the four-five areas where Indian households meaningfully spend going ahead. Consumer behaviour and patterns will be aligned to that. What changes may be that in the ‘50s, if an economy was transitioning from $2,000 per capita to $3,000 maybe entertainment, walkman or things like those would be in demand and maybe in the ‘90s, it may add cable TV or something.

What has changed now is maybe OTT and maybe IPL as entertainment. So only the underlying is changed but the unmet need, incremental disposable incomes getting diverted into that consumer behaviour is going to be no different in our economy. There is no doubt about it.

We are a $3-trillion economy and even by IMF estimates, roughly in eight years we will be say double the size. Now $3 trillion becoming $6 trillion is a very meaningful number. We have had very few instances of that in the last 50-60 years where this kind of additional economic size has been created in economies. I can recall two. One particularly was Japan in the 50s and 60s and then China in the 90s particularly.

We are talking about another large economy, adding $3 trillion worth of economic potential for a lot of goods and services businesses which I think is a historical thing from an economic perspective. A lot of business will get generated and that is more important than India going to double income in the next eight years. Also important is it is not in six years, it is not so early. So, the point is that the economy has clearly embarked in that direction. The slope can be debated but the trend and the direction is very clear now.

Another lingering worry in the mind of the market in the last few days has been the way crude oil prices have shot up. However, even during phases of high inflation, growth has not been impacted a whole lot and crude oil price spike is not that big a worry for the Indian economy as our IT exports are going up, the macros are very different. What are your thoughts on that?

Excellent perspective. Every time crude reached such levels in the past, we had a chaos in the economy from the prospects of inflation and prospects of the government balance sheet and then there were calls for subsidy and all kinds of oil price regimes that came into picture.

At one point, we also had oil bonds and some refiners had to sell them at a loss. But now we can see an excellent state of affairs. In the last 20 odd years, for the first time, our IT exports are in excess of $150 billion for this fiscal, which is sufficient to provide for our energy imports, which is largely crude. This has not happened in the past.

It is no wonder that crude is almost lingering around $100 and we still do not have a big hue and cry particularly from the economists and government policymakersThe reason primarily is after many years, we are able to largely fund our energy imports through our services exports.

It is also interesting that the landscape of outlook for fossil fuel has meaningfully changed. There might be plenty of reasons – geopolitical and all – why crude is where it is. But the reality is that the long-term outlook for crude is not that great. It is unlikely that it will be able to for a long period of time. That also means that it creates a very important angle, a higher price of fossil fuel or carbon emitting fuel basically creates the business case for green fuel or sustainable methods of energy generation and accelerates their adoption.

The last time crude reached such levels and prices went that high, we saw the consumers move towards diesel and we had a big uptick in diesel car sales in the 2012-13 era. Then it created more issues with the government balance sheet because diesel was subsidised far more than petrol. But nevertheless, now in the era that we are today, the future is clearly green. The source of energy generation would be more environmentally compliant. Higher fossil fuel prices only make those business cases more viable.

In any case, we are able to fund our crude or energy inputs through our IT exports and interestingly the long-term outlook, at least for fossil fuel prices, are not something even close to what it is now. Now what it does is in the near term, it pushes up inflation because crude is an imported inflation and it also has an effect on crude derivatives which are in terms of chemicals or petroleum products of various order. That is a botheration for individual businesses or sectors but I think that is part of the cycle. The outlook will eventually normalise.

What are your thoughts on the companies you have in your portfolio. Is the worst of margin pressure done in the third quarter or could it remain an issue even in the fourth quarter?

That is the most talked about question in the investment community as of now. For the last three-four months in particular, we had the WPI running in double digits and the CPI was running between 4% and 6%. That was a sign that the wholesale prices are kind of up but consumer prices are not being pushed. So it was very apparent that we are going to run into margin pressure on corporates in Q3.

We also need to keep in mind that at the beginning of corona in 2020, corporate India was very aggressive in cutting costs. We were trending on the higher side of aggregate margins. So, some bit of normalisation was on the anvil but it also happened that the steep raw material cost pressures have compressed margins.

Going ahead, it is important to see how many sectors and businesses are able to pass on those incremental costs. That is a function of growth. If we are seeing some sectors continuing to report compressed margins to whatever degree that has been reported, that is a sign that they are not confident if they will be able to push price and if the demand will sustain or not. They would rather sustain demand with a little lower profit and see if they can raise price later. There would be some businesses which will be able to push up price a little without impacting demand. It is typically called demand elasticity in economics. In terms of margin expectation, I would say it is too early to say that margins are going to meaningfully move up because the mean was never what we saw in the last calendar year.

It was actually on the higher side of trend in terms of corporate India’s margins. But can margins normalise upwards from here on? The answer is yes and that is largely a function of how raw material inflation plays out. We are rocking into a time zone where corona related disruptions are subsiding globally. There are more capacities coming on stream and so the supply chain related disruptions should normalise.

We should have at least some relief on shortages of raw materials which in my view is a primary reason why we have seen raw material inflation rather than anything else. The demand has recovered to pre-Covid levels in most sectors but it has not shot up to a level wherein there is sheer shortage and prices need to go up. I would say more than 50% of the rise would be attributed to lack of supplies and which is where the earlier question of the companies getting into a capex mode is a sign that they can see that the demand will continue. There is a long runway of demand and we might as well expand capacity and create supplies. That would be the right way to bring down inflation as well as create jobs and normalise margins.

Leave a comment

Vijay Gomatam

Consultant – Investment Banking

Vijay Gomatam has over 20 years of banking experience across M&A, corporate finance, capital markets, and corporate banking, with a strong focus on cross-border deal origination and execution across India, Southeast Asia, Japan, and Australia. He has deep sector expertise in industrials, IT services, media, and telecom, with extensive experience in India - Southeast Asia and India–Japan transactions. Vijay previously served as Director at MUFG Bank, Singapore, where he led the India - Japan M&A corridor, and earlier worked with Deutsche Bank, Merrill Lynch, Houlihan Lokey, and Edelweiss Alternative Asset Advisors.

His transaction experience includes Motherson Group’s acquisition of TSE-listed Yachiyo Industries, Takahata India’s stake sale to SPRL, Toppan Form’s acquisition of PT RDS in Indonesia, Mitsui’s investment in FKS Food & Agri, CVC’s investment in PT LinkNet, and capital market transactions for Southeast Asian media and telecom clients including SingTel, Axiata, and Bakrie Group.

He holds an MBA from IIM Calcutta and a B.E. (Hons.) from Nanyang Technological University, Singapore.

Akbar Khan

Senior Advisor – Investment Banking

Akbar Khan has over twenty years of experience across M&A advisory, Private Equity, and Corporate M&A, along with a decade as an entrepreneur and operator. He has held senior roles at Bank of America Merrill Lynch in India and London, where he led Telecom & Technology Investment Banking, Private Equity coverage, and M&A, and at General Electric, where he served as Head of Corporate Development and M&A for India and the MENA region. He has advised global corporates and financial sponsors including Reuters Plc, Telecom Italia, Hellenic Telecom, MTN, Tata Group, Apax Partners, Warburg Pincus, and TA Associates, and has led several notable transactions. These include advising E2E Networks on

its USD 50M capital raise, QuEST Global on its USD 75M Series B private placement to Warburg Pincus, Rain Technologies on its USD 65M Series A financing from QED Investors and Invus, Augnito.ai on its Pre-Series A raise from Apollo Hospitals Group, Tata Consultancy Services on the acquisition of Citigroup’s captive back-office unit, Forthnet in Greece on the acquisition of Netmed, and Telecom Italia on the sale of Cosmote via a leveraged buyout by Apax Partners and TPG.

In addition, Akbar co-founded and served as CEO of Rain Technologies India an earned wage access fintech platform.

He holds an MBA from London Business School and is a UK-qualified Chartered Accountant.

Shreyan ML

Managing Director – Healthcare & Pharma

Shreyan ML leads the healthcare and pharma investment banking practice and brings over 15 years of experience across investment banking, corporate M&A, and management consulting within the pharmaceutical sector. Prior to joining MAPE, he worked with Spark Capital, Strides Group, Wanbury Limited, and Tata Strategic Management Group.

His deal experience includes advising Curatio Healthcare on the sale of its business to Torrent Pharmaceuticals; Sale of TTK’s human pharma business to Bharat Serums; Glenmark Pharmaceuticals on the sale of the Razel brand to KKR-backed JB Chemicals & Pharma and the sale of nine dermatology brands to Eris Oaknet.

As Corporate M&A Head at Strides Group, he was involved in thesale of Agila to Mylan and led the animal health strategy at Sequent Scientific, executing over 12 transactions including fundraises and cross-border acquisitions.

He holds an MBA from IIM Indore and is a computer engineer from NIT Karnataka.

Arjun Mukherjee

Managing Director – Investment Banking

Arjun Mukherjee brings over 20 years of investment banking experience, with a strong focus on mergers & acquisitions and capital raising across Industrials, Education, Telecom, Cement, and Healthcare sectors. Prior to joining InCred Capital, he was part of the senior leadership team at MAPE Advisory Group for over a decade and has previously worked with Lazard, Ambit Capital, and Macquarie Capital.

His deal experience includes advising Veranda Learning on multiple acquisitions and its IPO, Emami on its bid for Paras Pharma, HeidelbergCement on the acquisitions of Mysore Cement and Indo Rama Cement, Italcementi on the acquisition of Sri Vishnu Cement along with an open offer, Bharti Airtel on the acquisitions of Hexacom India and the Spice Calcutta circle, as well as the sale of NLD rights to VSNL, Advent on its bid for Lafarge India.

He has also advised Jagdale Industries on the sale of its electrolyte drinks brand to Johnson & Johnson, promoters of Orissa Sponge on stake sales to Bhushan Steel and Monnet Ispat and on takeover defence, Fortis Healthcare on takeover defence and the sale of a minority stake to Khazanah, ICI India on the sale of its Nitrocellulose business to Actis and its rubber chemicals business, Jai Balaji Industries on the sale of its DI pipe unit and on QIP fund raising, Orbit Corporation and Ansal APIL on QIP-led equity fund raises, Walton Street Capital on raising a USD 500 million India-focused real estate fund, and on acquisition debt funding for the purchase of the RL Fine Chem API business.

Ashish Ambwani

Managing Director – Investment Banking

Ashish Ambwani has two decades of investment banking experience with a focus on cross-border M&A and Private Equity, and deep sector expertise across Consumption &Retail, Industrials and Digital businesses. He previously served as Director at Lazard for over 12 years and began his career at KPMG.

He has worked on numerous transactions including Osam Dairy’s sale to Dodla Dairy, Livpure’s capital raise from M&G Investments, QIMA’s acquisition of EFRAC Limited, Raymond Consumer Care’s FMCG sale to Godrej Consumer, IPO of Ethos Limited, Manohar Packaging’s sale to Parksons Packaging, MM Polytech’s sale to Huhtamaki, YY Inc.’s acquisition of Bigo, Kama Ayurveda’s fund raise and sale to Puig, Magnet360’s sale to Mindtree, Danone’s acquisition of Wockhardt nutrition assets, UCB’s sale of Indian brands to Dr Reddy’s, Sabero Organics’ sale to Coromandel, International Paper on its acquisition of AP Paper, Avantor on its acquisition of RFCL.

He holds an MBA from IIM Lucknow and a has a degree in Electrical & Electronics Engineering from NIT Trichy.

Jacob Mathew

Consultant- Investment Banking

Jacob Mathew brings over 25 years of experience in investment banking, private equity, and fundraising. He co-founded MAPE Advisory, a boutique investment bank focused on mid-market companies. Prior to MAPE, he was a Vice President (M&A) at Merrill Lynch India and played a key role in setting up the corporate finance practice at PwC India.

He has worked and led numerous transactions including the acquisition of Coats Viyella’s garment business by the AV Birla Group, the sale of Burnol and Coldarin brands, Dr Reddy’s buyout of American Remedies, and the sale of Diamond Dychem to Ciba AG. At MAPE, he led transactions across technology, telecommunications, consumer, healthcare, and retail sectors. His key clients include Coffee Day Enterprises, Strides, Igarashi Motors, J&J India, and Jyothi Labs.

He holds a PGDM from IIM Calcutta and is a Civil Engineer.

M Ramprasad

Consultant – Investment Banking

M Ramprasad has over 25 years of experience across investment banking, private equity, and fundraising. He co-founded MAPE Advisory, a boutique Indian investment bank focused on mid-market companies, which later merged with the Investment banking team at InCred in 2020. Prior to MAPE, he was a Senior Vice President at Merrill Lynch India, leading South India operations.

He has led marquee transactions for leading business groups including Tata Group, DuPont, ICICI Bank, Dr Reddy’s, and Sify, and at MAPE advised on landmark deals across manufacturing, infrastructure, and financial services. His key clients include Murugappa Group, ELGi Equipments, Curatio, Jyothi Labs, Karvy Financial Group, Star Health, and CRH Group.

He holds a PGDM from BIM Trichy and a degree in Chemistry.

Sanjay Singh

Head of Investment Banking – InCred Capital

Sanjay Singh is the Head of Investment Banking at InCred Capital, where he leads coverage across both advisory and equity capital markets. He brings over 20 years of experience across investment banking, strategy, and operations, with deep expertise in the pharmaceuticals and healthcare sectors.

Prior to joining InCred, he held leadership roles at BDA Partners as Head of India and Co-Head of Healthcare Asia, and at KPMG as Partner and Head of Life Sciences in India. He has also worked with Dr. Reddy’s Laboratories and Glenmark Pharmaceuticals.

His transaction experience includes advising Chemfield Cellulose on its divestment to Oji Holdings, Archimica S.p.A. on its acquisition by PI Industries, Synokem Pharmaceuticals on growth investment from TA Associates, Isagro SpA on the divestment of Isagro Asia Agrochemicals to PI Industries, SMT on its equity raise from Morgan Stanley Private Equity, Astec LifeSciences on the sale of equity to Godrej Agrovet and Nihon Nohyaku on its acquisition of Hyderabad Chemical Limited amongst others.

Sanjay holds an MBA from IIM Bangalore and a B Tech from IIT BHU.